Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 11, 2026 05:00 ET | Source: HepaRegeniX

HepaRegeniX Completes Phase Ib Study of HRX-215 to Enhance Liver Regeneration in Patients Undergoing Minor Liver Resection

HepaRegeniX announced the completion of the Phase Ib minor resection study of lead candidate HRX-215 for liver regeneration.